Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Lactoferrin Market, by Function
1.4.2 North America Lactoferrin Market, by Application
1.4.3 North America Lactoferrin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Lactoferrin Market by Function
Chapter 4. North America Iron absorption Market by Country
4.1 North America Intestinal flora protection Market by Country
4.2 North America Immune cell stimulation Market by Country
4.3 North America Antioxidant Market by Country
4.4 North America Antibacterial Market by Country
4.5 North America Anti-inflammatory Market by Country
Chapter 5. North America Lactoferrin Market by Application
5.1 North America Pharmaceuticals Market by Country
5.2 North America Food & Beverages Market by Country
5.3 North America Personal Care Products Market by Country
5.4 North America Infant Formula Market by Country
5.5 North America Sports & Functional Foods Market by Country
5.6 North America Animal Feed Market by Country
Chapter 6. North America Lactoferrin Market by Country
6.1 USA Lactoferrin Market
6.1.1 USA Lactoferrin Market by Function
6.1.2 USA Lactoferrin Market by Application
6.2 Canada Lactoferrin Market
6.2.1 Canada Lactoferrin Market by Function
6.2.2 Canada Lactoferrin Market by Application
6.3 Mexico Lactoferrin Market
6.3.1 Mexico Lactoferrin Market by Function
6.3.2 Mexico Lactoferrin Market by Application
6.4 Rest of North America Lactoferrin Market
6.4.1 Rest of North America Lactoferrin Market by Function
6.4.2 Rest of North America Lactoferrin Market by Application
Chapter 7. Company Profiles
7.1 Royal FrieslandCampina N.V.
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 Glanbia PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3.3 Segmental and Regional Analysis
7.4 Moringa Milk Industry Co., Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Geographical Expansions:
7.5 Ventria Bioscience, Inc. (InVitria)
7.5.1 Company Overview
7.6 Farbest Brands
7.6.1 Company Overview
7.7 Bega Cheese Ltd (Tatura Milk Industries Ltd.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Product Launches and Product Expansions:
7.7.4.2 Geographical Expansions:
7.8 MP Biomedicals LLC (Valiant Co., Ltd.)
7.8.1 Company Overview
7.9 Synlait Milk Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Partnerships, Collaborations, and Agreements:
7.9.4.2 Geographical Expansions:
7.10. Pharming Group NV
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
Unique Offerings 
